Skip to content

Evaluation of efficacy of microdermabrasion in association with Tacrolimus oint plus Elocome oint in compare with pimecrolimus oint plus Elocome oint in patients with vitiligo

Evaluation of efficacy of microdermabrasion in association with Tacrolimus ointment plus Elocome ointment in compare with pimecrolimus ointment plus Elocome oint in patients with vitiligo

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT201212059800N3
Enrollment
47
Registered
2013-08-06
Start date
2013-08-23
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Vitiligo. One of the common pigmentation disorders , Depigmented pathes in diffrent size

Interventions

Intervention 1: Intervention 1: Microdermabration combined with two topical cream (Tacrolimous + Elocome). Intervention 2: Intervention2: combination of two topical creams (Tacrolimous + Elocome).
Treatment - Devices
Treatment - Drugs
Intervention 1: Microdermabration combined with two topical cream (Tacrolimous + Elocome)
Intervention2: combination of two topical creams (Tacrolimous + Elocome)

Sponsors

Tehran University of Medical Science
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria:age range 18 to 70 years; existence of 2 vitiligo symmetrical patch in both side of body; not taking local drugs from 2 weeks before the study; no photo therapy from one month before the study; stable for 6 months prior to study. Exclusion criteria: evidence of local infection at the site of testing; evidence of spontaneous re-pigmentation; abnormal liver function tests & thyroid tests; pregnant and lactating mothers; no satisfaction to participate at any stage of the study.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Patient Clinical Healing. Timepoint: In the weeks 0, 2, 4, 6 & 8. Method of measurement: According to two dermatologist assessment based on digital photos of therapeutic sessions (score 0-4).

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr.Somaih Hejazi

Shahid Beheshti Unuversity of Medical Science

dr.s.hejazi@gmail.com+98 21 2274 1507

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026